|
V64444
|
(Rac)-SHIN2
|
2204289-53-0 |
(Rac)-SHIN2 is a serine hydroxymethyltransferase (SHMT) inhibitor (antagonist) with a 1,4-dihydropyran[2,3-c]pyrazole structure. |
|
V64529
|
(Rac)-Taltobulin intermediate-1 (2-((tert-butoxycarbonyl)(methyl)amino)-3-methyl-3-phenylbutyric acid)
|
676487-35-7 |
(Rac)-Taltobulin intermediate-1 is an intermediate in the synthesis/preparation of Taltobulin. |
|
V60667
|
(Rac)-Tivantinib ((Rac)-ARQ 197; (Rac)-ARQ 198)
|
1239986-50-5 |
(Rac)-Tivantinib is the inactive isomer of Tivantinib and could be utilized as a control compound in experiments. |
|
V61460
|
(Rac)-TTA-P2 ((Rac)-T-Type calcium channel inhibitor)
|
918430-49-6 |
(Rac)-TTA-P2 is the inactive isomer of TTA-P2 and could be utilized as a control compound in experiments. |
|
V61032
|
(rel)-Tivantinib ((rel)-ARQ 197; (rel)-(3R,4R)-ARQ 198)
|
905853-99-8 |
(rel)-Tivantinib (Compound 9) is a potent and selective inhibitor of the receptor tyrosine kinase c-MET. |
|
V61563
|
(S)-(-)-MRJF22
|
2757301-90-7 |
(S)-(-)-MRJF22 is the haloperidol metabolite II valproate. |
|
V57000
|
(S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid ((S)-3-(4-Hydroxyphenyl)lactic acid)
|
23508-35-2 |
(S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid (compound 1) is a metabolite extracted from the culture medium of Leuconostoc mesenteroides. |
|
V61058
|
(S)-ar-Curcumene ((+)-alpha-Curcumene)
|
4176-06-1 |
(S)-ar-Curcumene ((+)-alpha-Curcumene) is a natural compound. |
|
V58129
|
(S)-BAY 73-6691
|
794568-91-5 |
(S)-BAY 73-6691 is the inactive isomer of BAY 73-6691 and could be utilized as a control compound in experiments. |
|
V59441
|
(S)-Benzyl 2-cyclopropyl-2-hydroxyacetate
|
2414393-48-7 |
(S)-Benzyl 2-cyclopropyl-2-hydroxyacetate is an intermediate reactant in the synthesis/preparation of Camptothecin. |
|
V64363
|
(S)-BINAP
|
76189-56-5 |
(S)-BINAP is the inactive isomer of (R)-BINAP and could be utilized as a control compound in experiments. |
|
V59650
|
(S)-BRD9500
|
1630760-76-7 |
(S)-BRD9500 is the inactive isomer of BRD9500 and could be utilized as a control compound in experiments. |
|
V61409
|
(S)-Canocapavir ((S)-ZM-H1505R)
|
2137847-77-7 |
Canocapavir is an isomer of Canocapavir. |
|
V64515
|
(S)-ErSO
|
2407860-34-6 |
(S)-ErSO is a right-handed ErSO. |
|
V59555
|
(S)-GLPG0974
|
2326220-69-1 |
(S)-GLPG0974 is the inactive isomer of GLPG0974 and could be utilized as a control compound in experiments. |
|
V62157
|
(S)-GSK-3685032
|
2170142-58-0 |
(S)-GSK-3685032 is the inactive isomer of GSK-3685032 and could be utilized as a control compound in experiments. |
|
V59939
|
(S)-Imlunestrant tosylate ((S)-LY-3484356 tosylate)
|
2408840-43-5 |
(S)-Imlunestrant tosylate ((S)-LY-3484356) is the (S)-enantiomer of Imlunestrant. |
|
V57201
|
(S)-Lisofylline ((S)-Lisophylline)
|
100324-80-9 |
(S)-Lisofylline ((S)-Lisophylline)) is an optically active enantiomer of lisofylline (LSF). |
|
V62311
|
(S)-mchm5U
|
89665-83-8 |
(S)-mchm5U is a hydroxylated form of mcm5U and may be present in tRNA of the silkworm Bombyx mori. |
|
V57941
|
(S)-NODAGA-tris(t-Bu ester) ((S)-NODAG)
|
438553-50-5 |
(S)-NODAGA-tris(t-Bu ester) ((S)-NODAG) is a NODAGan analogue. |